| Financial Year |
September 30 2022 |
| Monetary Funds |
172,231,942.22 |
| Held-for-trading Financial Assets |
100,312,337.84 |
| Notes Receivable |
-- |
| Accounts Receivable |
169,205,913.48 |
| Advances to Suppliers |
61,176,737.31 |
| Other Receivables |
30,953,446.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
175,926,173.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,596,652.79 |
| Total Current Assets |
724,968,471.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
399,256.34 |
| Investment Properties |
-- |
| Fixed Assetes |
46,566,645.75 |
| Under-construction Projects |
62,081,604.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
268,855,435.21 |
| R&D expenses |
-- |
| Goodwill |
4,158,218.39 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
4,984,604.72 |
| Other Non-Current Assets |
1,800,375.94 |
| Sub-Total of Non-Current Assets |
388,888,825.51 |
| Total Assets |
1,113,857,296.98 |
| Short-Term Loans |
89,220,032.16 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
49,625,458.30 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,263,267.54 |
| Taxes Payable |
1,049,744.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,247,089.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
44,280.00 |
| Other Current Liabilities |
4,976,166.78 |
| Sub-Total of Current Liabilities |
241,067,262.47 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,151,020.90 |
| Other Non-Current Liabilities |
67,851,901.72 |
| Sub-Total of Non-Current Liabilities |
69,002,922.62 |
| Total Liabilities |
310,070,185.09 |
| Paid-In Capital(Or Share Stock) |
83,110,000.00 |
| Capital Surplus |
484,502,994.53 |
| Surplus Reserve |
15,679,827.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
220,521,761.55 |
| Minority Stockholder's Interest |
-27,471.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
803,814,583.19 |
| Owner's Equity（Stockholder's Equity） |
803,787,111.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,113,857,296.98 |
